Semaglutide has rising clinical utility, both for its original purpose in managing type-II diabetes symptoms and, more recently, as a tool for weight management
FDA PCAC July 2026: 29 Days Out What Researchers Need to Know Before the Hearing The FDA Pharmacy Compounding Advisory Committee convenes July 2324, 2026 to rule on 503A status for BPC-157, TB-500, KPV, MOTS-c, DSIP, Semax, and Epitalon
Why did Weight Watchers discontinue the program
This control has enabled consistent growth in the GLP-1 receptor agonist segment
Rare side effects like redness
GLP-1 receptor agonists available in the UK include: Semaglutide : Ozempic (for type 2 diabetes), Wegovy (for weight management), and Rybelsus (oral formulation for type 2 diabetes) Dulaglutide (Trulicity) for type 2 diabetes Liraglutide : Victoza (for type 2 diabetes), Saxenda (for weight management) Exenatide (Byetta) for type 2 diabetes Most GLP-1 receptor agonists are administered via subcutaneous injection , with dosing frequencies varying from twice daily to once weekly depending on the specific formulation